Evidence 1
Activity
Activity
2% Hemolysis
Toxicity
65 µM
Hemolytic
Cytotoxic
2% Hemolysis | 65 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Development of a Novel Hybrid Antimicrobial Peptide for Targeted Killing of Pseudomonas Aeruginosa. | Eur J Med Chem | 2020